Teva (TEVA) (TLAB) (TLB) (GHDX) (HALO) (JPM) Ratings Reiterated

Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA), Tellabs, Inc. (NASDAQ: TLAB), Talbots (NYSE: TLB), Genomic Health, Inc. (NASDAQ: GHDX), Halozyme Therapeutics (NASDAQ: HALO) and JPMorgan Chase & Co. (NYSE: JPM) had ratings on them reiterated by analysts.

Deutsche Bank (NYSE:DB) reiterated its "Buy" rating on Teva Pharmaceutical Industries Ltd (TEVA). They have a price target of $46.00 on the company.

JPMorgan Chase & Co. (NYSE:JPM) reiterated its "Underweight" rating on Tellabs, Inc. (TLAB).

Nomura reiterated its "Buy" rating on Talbots (TLB).

Canaccord Genuity reiterated its "Hold" rating on Genomic Health, Inc. (GHDX). They have a price target of $23.00 on the company.

Wedbush reiterated its "Outperform" rating on Halozyme Therapeutics (HALO). They have a price target of $17.00 on the company.

Nomura reiterated its "Buy" rating on JPMorgan Chase & Co. (JPM).